{"id":"https://openalex.org/W4390972071","doi":"https://doi.org/10.7759/cureus.52506","title":"A Case Report of Drug Interactions Between Nirmatrelvir/Ritonavir and Tacrolimus in a Patient With Systemic Lupus Erythematosus","display_name":"A Case Report of Drug Interactions Between Nirmatrelvir/Ritonavir and Tacrolimus in a Patient With Systemic Lupus Erythematosus","publication_year":2024,"publication_date":"2024-01-18","ids":{"openalex":"https://openalex.org/W4390972071","doi":"https://doi.org/10.7759/cureus.52506","pmid":"https://pubmed.ncbi.nlm.nih.gov/38371142","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10874239"},"language":"en","primary_location":{"id":"doi:10.7759/cureus.52506","doi":"https://doi.org/10.7759/cureus.52506","is_oa":true,"landing_page_url":"http://dx.doi.org/10.7759/cureus.52506","pdf_url":"https://www.cureus.com/articles/223078-a-case-report-of-drug-interactions-between-nirmatrelvirritonavir-and-tacrolimus-in-a-patient-with-systemic-lupus-erythematosus.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.cureus.com/articles/223078-a-case-report-of-drug-interactions-between-nirmatrelvirritonavir-and-tacrolimus-in-a-patient-with-systemic-lupus-erythematosus.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000997855","display_name":"Nanae Yamamoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I135598925","display_name":"Kyushu University","ror":"https://ror.org/00p4k0j84","country_code":"JP","type":"education","lineage":["https://openalex.org/I135598925"]},{"id":"https://openalex.org/I4210097767","display_name":"Kyushu University Hospital","ror":"https://ror.org/00ex2fc97","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I135598925","https://openalex.org/I4210097767"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Nanae Yamamoto","raw_affiliation_strings":["Department of Pharmacology and Therapeutics, Kyushu University Hospital, Fukuoka, JPN",". Faculty of Medical Sciences, Department of Medical Education, Kyushu University, Fukuoka, JPN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Therapeutics, Kyushu University Hospital, Fukuoka, JPN","institution_ids":["https://openalex.org/I4210097767"]},{"raw_affiliation_string":". Faculty of Medical Sciences, Department of Medical Education, Kyushu University, Fukuoka, JPN","institution_ids":["https://openalex.org/I135598925"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102024462","display_name":"Yuichi Tsuchiya","orcid":"https://orcid.org/0000-0002-1947-1107","observed_orcids":["https://orcid.org/0000-0002-1947-1107"]},"institutions":[{"id":"https://openalex.org/I135598925","display_name":"Kyushu University","ror":"https://ror.org/00p4k0j84","country_code":"JP","type":"education","lineage":["https://openalex.org/I135598925"]},{"id":"https://openalex.org/I4210097767","display_name":"Kyushu University Hospital","ror":"https://ror.org/00ex2fc97","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I135598925","https://openalex.org/I4210097767"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yuichi Tsuchiya","raw_affiliation_strings":["Department of Pharmacology and Therapeutics, Kyushu University Hospital, Fukuoka, JPN",". Faculty of Medical Sciences, Department of Medical Education, Kyushu University, Fukuoka, JPN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Therapeutics, Kyushu University Hospital, Fukuoka, JPN","institution_ids":["https://openalex.org/I4210097767"]},{"raw_affiliation_string":". Faculty of Medical Sciences, Department of Medical Education, Kyushu University, Fukuoka, JPN","institution_ids":["https://openalex.org/I135598925"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113098662","display_name":"Mio Fukuda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I135598925","display_name":"Kyushu University","ror":"https://ror.org/00p4k0j84","country_code":"JP","type":"education","lineage":["https://openalex.org/I135598925"]},{"id":"https://openalex.org/I4210097767","display_name":"Kyushu University Hospital","ror":"https://ror.org/00ex2fc97","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I135598925","https://openalex.org/I4210097767"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mio Fukuda","raw_affiliation_strings":["Department of Pharmacology and Therapeutics, Kyushu University Hospital, Fukuoka, JPN",". Faculty of Medical Sciences, Department of Medical Education, Kyushu University, Fukuoka, JPN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Therapeutics, Kyushu University Hospital, Fukuoka, JPN","institution_ids":["https://openalex.org/I4210097767"]},{"raw_affiliation_string":". Faculty of Medical Sciences, Department of Medical Education, Kyushu University, Fukuoka, JPN","institution_ids":["https://openalex.org/I135598925"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077232803","display_name":"Hiroaki Niiro","orcid":"https://orcid.org/0000-0003-0914-9066","observed_orcids":["https://orcid.org/0000-0003-0914-9066","https://orcid.org/0000-0003-3816-1611"]},"institutions":[{"id":"https://openalex.org/I135598925","display_name":"Kyushu University","ror":"https://ror.org/00p4k0j84","country_code":"JP","type":"education","lineage":["https://openalex.org/I135598925"]},{"id":"https://openalex.org/I4210097767","display_name":"Kyushu University Hospital","ror":"https://ror.org/00ex2fc97","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I135598925","https://openalex.org/I4210097767"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroaki Niiro","raw_affiliation_strings":["Faculty of Medical Sciences, Department of Medical Education, Kyushu University, Fukuoka, JPN",". Department of Pharmacology and Therapeutics, Kyushu University Hospital, Fukuoka, JPN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Faculty of Medical Sciences, Department of Medical Education, Kyushu University, Fukuoka, JPN","institution_ids":["https://openalex.org/I135598925"]},{"raw_affiliation_string":". Department of Pharmacology and Therapeutics, Kyushu University Hospital, Fukuoka, JPN","institution_ids":["https://openalex.org/I4210097767"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5018976944","display_name":"Takeshi Hirota","orcid":"https://orcid.org/0000-0002-4846-3421","observed_orcids":["https://orcid.org/0000-0002-4846-3421"]},"institutions":[{"id":"https://openalex.org/I135598925","display_name":"Kyushu University","ror":"https://ror.org/00p4k0j84","country_code":"JP","type":"education","lineage":["https://openalex.org/I135598925"]},{"id":"https://openalex.org/I4210097767","display_name":"Kyushu University Hospital","ror":"https://ror.org/00ex2fc97","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I135598925","https://openalex.org/I4210097767"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Takeshi Hirota","raw_affiliation_strings":["Department of Pharmacology and Therapeutics, Kyushu University Hospital, Fukuoka, JPN",". Faculty of Medical Sciences, Department of Medical Education, Kyushu University, Fukuoka, JPN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Therapeutics, Kyushu University Hospital, Fukuoka, JPN","institution_ids":["https://openalex.org/I4210097767"]},{"raw_affiliation_string":". Faculty of Medical Sciences, Department of Medical Education, Kyushu University, Fukuoka, JPN","institution_ids":["https://openalex.org/I135598925"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5018976944"],"corresponding_institution_ids":["https://openalex.org/I135598925","https://openalex.org/I4210097767"],"apc_list":null,"apc_paid":null,"fwci":0.9644,"has_fulltext":true,"cited_by_count":4,"citation_normalized_percentile":{"value":0.67327745,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":91,"max":96},"biblio":{"volume":"16","issue":"1","first_page":"e52506","last_page":"e52506"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9672999978065491,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9672999978065491,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","score":0.004100000020116568,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10373","display_name":"Renal Transplantation Outcomes and Treatments","score":0.004000000189989805,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nirmatrelvir-ritonavir","display_name":"nirmatrelvir/ritonavir","score":0.9900000095367432},{"id":"https://openalex.org/keywords/tacrolimus","display_name":"tacrolimus","score":0.9950000047683716},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.8690000176429749},{"id":"https://openalex.org/keywords/cyp3a-inhibition","display_name":"CYP3A inhibition","score":0.9020000100135803},{"id":"https://openalex.org/keywords/ritonavir","display_name":"ritonavir","score":0.8389999866485596},{"id":"https://openalex.org/keywords/systemic-lupus-erythematosus","display_name":"systemic lupus erythematosus","score":0.9359999895095825},{"id":"https://openalex.org/keywords/covid-19-treatment","display_name":"COVID-19 treatment","score":0.9229999780654907},{"id":"https://openalex.org/keywords/tacrolimus-toxicity","display_name":"tacrolimus toxicity","score":0.9340000152587891},{"id":"https://openalex.org/keywords/immunosuppressive-drugs","display_name":"immunosuppressants","score":0.7459999918937683},{"id":"https://openalex.org/keywords/covalent-attachment","display_name":"covalent binding","score":0.49000000953674316},{"id":"https://openalex.org/keywords/therapeutic-drug-monitoring","display_name":"therapeutic drug monitoring","score":0.3630000054836273}],"concepts":[{"id":"https://openalex.org/C2909675724","wikidata":"https://www.wikidata.org/wiki/Q411648","display_name":"Tacrolimus","level":3,"score":0.9694856405258179},{"id":"https://openalex.org/C2779298103","wikidata":"https://www.wikidata.org/wiki/Q422618","display_name":"Ritonavir","level":5,"score":0.9557074904441833},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.6779052019119263},{"id":"https://openalex.org/C11824378","wikidata":"https://www.wikidata.org/wiki/Q5014970","display_name":"CYP3A","level":4,"score":0.6405051946640015},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.629026472568512},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5860766172409058},{"id":"https://openalex.org/C2776912625","wikidata":"https://www.wikidata.org/wiki/Q1485","display_name":"Systemic lupus erythematosus","level":3,"score":0.48493364453315735},{"id":"https://openalex.org/C97320921","wikidata":"https://www.wikidata.org/wiki/Q718753","display_name":"Drug interaction","level":3,"score":0.454969197511673},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3420906066894531},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.31797224283218384},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2559434175491333},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.17873302102088928},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.11198794841766357},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.08284777402877808},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.0680827796459198},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0},{"id":"https://openalex.org/C62231903","wikidata":"https://www.wikidata.org/wiki/Q1057","display_name":"Metabolism","level":2,"score":0.0},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.7759/cureus.52506","doi":"https://doi.org/10.7759/cureus.52506","is_oa":true,"landing_page_url":"http://dx.doi.org/10.7759/cureus.52506","pdf_url":"https://www.cureus.com/articles/223078-a-case-report-of-drug-interactions-between-nirmatrelvirritonavir-and-tacrolimus-in-a-patient-with-systemic-lupus-erythematosus.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10874239","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10874239","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10874239/pdf/cureus-0016-00000052506.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"Text"},{"id":"pmid:38371142","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38371142","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"Case Reports"}],"best_oa_location":{"id":"doi:10.7759/cureus.52506","doi":"https://doi.org/10.7759/cureus.52506","is_oa":true,"landing_page_url":"http://dx.doi.org/10.7759/cureus.52506","pdf_url":"https://www.cureus.com/articles/223078-a-case-report-of-drug-interactions-between-nirmatrelvirritonavir-and-tacrolimus-in-a-patient-with-systemic-lupus-erythematosus.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[{"id":"https://openalex.org/G2625307413","display_name":"The search for accurate biomarkers for the early diagnosis of chronic kidney injury in patients after liver transplantation","funder_award_id":"21K15270","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"},{"id":"https://openalex.org/G5281965466","display_name":"Study on the identification and functional analysis of key molecules involved in immune tolerance after liver transplantation","funder_award_id":"20K16046","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"}],"funders":[{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4390972071.pdf","grobid_xml":"https://content.openalex.org/works/W4390972071.grobid-xml"},"referenced_works_count":13,"referenced_works":["https://openalex.org/W1574392124","https://openalex.org/W1999281243","https://openalex.org/W2031400172","https://openalex.org/W2087499594","https://openalex.org/W2104423175","https://openalex.org/W2127264836","https://openalex.org/W3119634521","https://openalex.org/W3189646261","https://openalex.org/W4280580040","https://openalex.org/W4281658656","https://openalex.org/W4292457905","https://openalex.org/W4293773230","https://openalex.org/W4381548986"],"related_works":["https://openalex.org/W4396620395","https://openalex.org/W4328135864","https://openalex.org/W4386571089","https://openalex.org/W4393231138","https://openalex.org/W4399817803","https://openalex.org/W4362472112","https://openalex.org/W4311940484","https://openalex.org/W4372183527","https://openalex.org/W4386385368","https://openalex.org/W4391274452"],"abstract_inverted_index":{"Nirmatrelvir/ritonavir":[0],"is":[1,22,51],"a":[2,15,26,73],"treatment":[3],"for":[4,92,166],"COVID-19":[5,98],"consisting":[6],"of":[7,29,49,78,107,123,129,154,169],"nirmatrelvir,":[8],"which":[9],"has":[10],"anti-SARS-CoV-2":[11],"activity,":[12],"and":[13,34,57,80,99,109],"ritonavir,":[14],"booster":[16],"to":[17,24,54,63,120,127],"maintain":[18],"blood":[19,86,114,135,147,160],"levels.":[20,87],"Ritonavir":[21],"known":[23],"be":[25,45,180],"potent":[27],"inhibitor":[28],"cytochrome":[30],"P450":[31],"3A":[32],"(CYP3A),":[33],"interactions":[35],"with":[36],"CYP3A-metabolized":[37],"drugs,":[38],"such":[39],"as":[40],"the":[41,76,105,111,121,140,143,164],"immunosuppressant":[42],"tacrolimus,":[43,110],"can":[44],"problematic.":[46],"Ritonavir's":[47],"inhibition":[48,153],"CYP3A":[50,152],"irreversible":[52],"due":[53,126],"covalent":[55],"binding,":[56],"its":[58,159],"inhibitory":[59],"effects":[60],"are":[61],"expected":[62],"persist":[64],"until":[65],"replaced":[66],"by":[67],"new":[68],"CYP3A.":[69],"Here,":[70],"we":[71],"report":[72],"case":[74],"where":[75],"combination":[77,106],"nirmatrelvir/ritonavir":[79,108,174],"tacrolimus":[81,85,91,113,130,146],"resulted":[82],"in":[83,145],"toxic":[84],"A":[88],"patient":[89],"on":[90],"systemic":[93],"lupus":[94],"erythematosus":[95],"(SLE)":[96],"developed":[97],"was":[100,149],"prescribed":[101],"nirmatrelvir/ritonavir.":[102],"After":[103],"starting":[104,173],"patient's":[112],"levels":[115,136,148],"became":[116],"abnormally":[117],"high,":[118],"leading":[119],"discontinuation":[122,178],"these":[124],"drugs":[125],"symptoms":[128],"toxicity.":[131],"Even":[132],"after":[133],"ritonavir":[134,155],"had":[137],"fallen":[138],"below":[139],"detection":[141],"limit,":[142],"decline":[144],"delayed.":[150],"The":[151],"persists":[156],"even":[157],"when":[158],"concentration":[161],"decreases,":[162],"emphasizing":[163],"need":[165],"careful":[167],"consideration":[168],"concomitant":[170],"medications":[171],"before":[172],"therapy.":[175],"Adjustments":[176],"or":[177],"may":[179],"necessary.":[181]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-01-19T00:00:00"}